A New Wave of Targeting ‘Undruggable’ Wnt Signaling for Cancer Therapy: Challenges and Opportunities
Aberrant Wnt signaling activation is frequently observed in many cancers. The mutation acquisition of Wnt signaling leads to tumorigenesis, whereas the inhibition of Wnt signaling robustly suppresses tumor development in various in vivo models. Based on the excellent preclinical effect of targeting...
Main Authors: | Woo-Jung Park, Moon Jong Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/8/1110 |
Similar Items
-
Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
by: Moon Jong Kim, et al.
Published: (2020-12-01) -
Editorial: Targeting the Wnt/β-catenin signaling pathway in cancer
by: Simone Patergnani, et al.
Published: (2022-09-01) -
WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?
by: Esther Martinez-Font, et al.
Published: (2021-11-01) -
Interactions between miRNAs and the Wnt/β-catenin signaling pathway in endometriosis
by: Yu Zhang, et al.
Published: (2024-02-01) -
Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss
by: Bu Young Choi
Published: (2020-07-01)